ADC Therapeutics SA (ADCT) Operating cash flow 2022–2025
ADC Therapeutics SA (ADCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$141.2MFY2025 · since FY2022: -$138.3M → -$141.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$141.2M | -14.0% |
| FY2024 | -$123.8M | -4.3% |
| FY2023 | -$118.7M | +14.2% |
| FY2022 | -$138.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT RevenueADCT Net incomeADCT Net marginADCT Gross profitADCT Gross marginADCT Operating incomeADCT Operating marginADCT Free cash flowADCT Capital expendituresADCT Return on equityADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Total liabilitiesADCT Shareholders’ equityADCT overview →